Definitive Healthcare Corp
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 18.2% | 19.0% | 20.6% | 20.8% | 21.8% | 23.6% | 26.1% | 23.3% | 15.1% | 31.9% | 40.4% | 26.5% | 28.3% | |
| 81.8% | 81.0% | 79.4% | 79.2% | 78.2% | 76.4% | 73.9% | 76.7% | 84.9% | 68.1% | 59.6% | 73.5% | 71.7% | |
| 16.5% | 17.5% | 16.0% | 15.9% | 11.6% | 14.4% | 15.7% | 13.1% | 12.6% | 16.2% | 11.6% | 12.2% | 13.2% | |
| 22.3% | 25.1% | 26.6% | 19.7% | 18.1% | 13.7% | 20.7% | 20.9% | 20.6% | 23.3% | 21.6% | 19.6% | 21.3% | |
| 534.0% | 96.3% | 105.0% | 659.1% | 437.7% | 236.3% | 386.1% | 83.6% | 99.4% | -219.6% | 68.2% | 85.7% | 4.3% | |
| -452.2% | -15.3% | -25.6% | -579.9% | -359.5% | -159.8% | -312.2% | -6.9% | -14.5% | 287.7% | -8.6% | -12.2% | 67.4% | |
| 6.0% | 5.9% | 6.0% | 5.9% | 6.0% | 5.6% | 4.1% | 4.9% | 5.0% | 4.7% | 4.7% | 4.8% | 4.8% | |
| -407.5% | -18.5% | -21.3% | -514.8% | -321.5% | -145.5% | -280.4% | -14.5% | -28.8% | -28.0% | -350.1% | -14.1% | -102.3% | |
| -26.8% | 1.8% | -1.2% | -34.4% | -21.9% | -9.5% | -18.4% | 0.8% | 0.9% | -0.1% | -6.1% | -0.6% | -1.4% | |
| -262.6% | -15.5% | -15.0% | -335.2% | -208.8% | -94.8% | -181.2% | -12.4% | -24.7% | -15.1% | -247.9% | -9.8% | -72.3% | |
| -381.6% | 7.1% | 4.7% | -488.8% | -294.6% | -118.8% | -253.0% | 14.0% | -0.3% | -8.3% | -321.7% | -9.4% | -81.8% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.